Skip to main content
SpringerLink
Log in

In response: Pyridostigmine in the treatment of orthostatic hypotension

  • LETTER TO THE EDITORS
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kaminski HJ (2003) Treatment of Myasthenia Gravis. In: Kaminksi HJ (ed) Myasthenia Gravis and Related Disorders. Humana Press, Totowa, NJ, pp 197–222

  2. Sandroni P, Opfer-Gehrking TL, Singer W, Low PA (2005) Pyridostigmine for treatment of neurogenic orthostatic hypotension: a follow-up survey study. Clin Auton Res 15:51–53

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Autonomic Disorders Center Mayo Clinic, Rochester, USA

    Paola Sandroni

Authors
  1. Paola Sandroni
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of all authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sandroni, P., on behalf of all authors. In response: Pyridostigmine in the treatment of orthostatic hypotension. Clin Auton Res 15, 423 (2005). https://doi.org/10.1007/s10286-005-0322-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10286-005-0322-3

Keywords

Search

Navigation